Superworth

NU Skin Enterprises price to book ratio NUS

Market value divided by the book value of the company's net assets, since 2010.

Today, Oct 23, 2026
0.4×
10-year median
2.5×
Against its 10-year history
4th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.3× to 5.8×
Peer median
2.9×

NU Skin Enterprises' price to book ratio is 0.4× as of Oct 23, 2026.

That is below its ten-year median of 2.5×, lower than on 96% of days in the last ten years.

Over that time it ranged from 0.3× in Jul 2026 to 5.8× in Aug 2018.

The median for 10 healthcare stocks of a similar size is 2.9×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.4×0.3×0.7×
20250.6×0.4×0.8×
20240.5×0.4×1.1×
20231.2×1.0×2.6×
20222.5×1.8×2.9×
20212.7×2.2×3.7×
20203.4×1.2×3.6×
20192.7×2.5×4.5×
20184.0×3.8×5.8×
20175.0×3.1×5.1×
20163.0×1.9×4.4×
20152.5×2.2×3.9×
20142.9×2.5×11.0×
201311.0×4.1×11.0×
20123.8×3.7×6.7×
20115.6×2.2×5.7×
20104.4×4.4×4.6×

Against its peers

Companies in Healthcare nearest NU Skin Enterprises' size, closest first, today.

CompanyPrice to book ratio
NUSNU Skin Enterprises0.4×
UTMDUtah Medical Products1.9×
ELMDElectromed4.1×
NATRNatures Sunshine Products1.3×
PLXProtalix BioTherapeutics2.9×
PDEXPro DEX4.2×
INFUInfuSystem4.7×
VMDViemed Healthcare2.6×
EMBCEmbectan/m
ARVNArvinas0.8×
NRCNRC Health74.1×
Peer median2.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on NU Skin Enterprises

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.